176 related articles for article (PubMed ID: 32458544)
1. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
Stewart SD; Ehrhart EJ; Davies R; Khanna C
Vet Comp Oncol; 2020 Dec; 18(4):811-817. PubMed ID: 32458544
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).
Hammond TN; Pesillo-Crosby SA
J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091
[TBL] [Abstract][Full Text] [Related]
3. Incidence of malignancy and outcomes for dogs undergoing splenectomy for incidentally detected nonruptured splenic nodules or masses: 105 cases (2009-2013).
Cleveland MJ; Casale S
J Am Vet Med Assoc; 2016 Jun; 248(11):1267-73. PubMed ID: 27172343
[TBL] [Abstract][Full Text] [Related]
4. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011).
Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256
[TBL] [Abstract][Full Text] [Related]
5. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
Davies O; Taylor AJ
Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
[TBL] [Abstract][Full Text] [Related]
6. Splenic mass diagnosis in dogs undergoing splenectomy according to breed size.
O'Byrne K; Hosgood G
Vet Rec; 2019 May; 184(20):620. PubMed ID: 31040215
[TBL] [Abstract][Full Text] [Related]
7. Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy.
Johnson KA; Powers BE; Withrow SJ; Sheetz MJ; Curtis CR; Wrigley RH
J Vet Intern Med; 1989; 3(3):160-6. PubMed ID: 2778749
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE
Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and Clinicopathologic Features of Splenic Neoplasia Based on Body Weight: 325 Dogs (2003-2013).
Sherwood JM; Haynes AM; Klocke E; Higginbotham ML; Thomson EM; Weng HY; Towle Millard HA
J Am Anim Hosp Assoc; 2016; 52(4):220-6. PubMed ID: 27259024
[TBL] [Abstract][Full Text] [Related]
10. Association between macroscopic appearance of liver lesions and liver histology in dogs with splenic hemangiosarcoma: 79 cases (2004-2009).
Clendaniel DC; Sivacolundhu RK; Sorenmo KU; Donovan TA; Turner A; Arteaga T; Bergman PJ
J Am Anim Hosp Assoc; 2014; 50(4):e6-10. PubMed ID: 25001171
[TBL] [Abstract][Full Text] [Related]
11. Gastric dilatation-volvulus as complication after surgical removal of a splenic haemangiosarcoma in a dog.
Marconato L
J Vet Med A Physiol Pathol Clin Med; 2006 Sep; 53(7):371-4. PubMed ID: 16922836
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic splenectomy for treatment of splenic hemangiosarcoma in a dog.
Collard F; Nadeau ME; Carmel EN
Vet Surg; 2010 Oct; 39(7):870-2. PubMed ID: 20723196
[TBL] [Abstract][Full Text] [Related]
13. Development of perioperative premature ventricular contractions as an indicator of splenic hemangiosarcoma and median survival times.
Panissidi AA; DeSandre-Robinson DM
Vet Surg; 2021 Nov; 50(8):1609-1616. PubMed ID: 34351008
[TBL] [Abstract][Full Text] [Related]
14. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic characteristics of biopsies from dogs undergoing surgery with concurrent gross splenic and hepatic masses: 125 cases (2012-2016).
Leyva FJ; Loughin CA; Dewey CW; Marino DJ; Akerman M; Lesser ML
BMC Res Notes; 2018 Feb; 11(1):122. PubMed ID: 29433531
[TBL] [Abstract][Full Text] [Related]
16. Transfusion practices for treatment of dogs undergoing splenectomy for splenic masses: 542 cases (2001-2012).
Lynch AM; O'Toole TE; Hamilton J
J Am Vet Med Assoc; 2015 Sep; 247(6):636-42. PubMed ID: 26331422
[TBL] [Abstract][Full Text] [Related]
17. Mass-to-splenic volume ratio and splenic weight as a percentage of body weight in dogs with malignant and benign splenic masses: 65 cases (2007-2008).
Mallinckrodt MJ; Gottfried SD
J Am Vet Med Assoc; 2011 Nov; 239(10):1325-7. PubMed ID: 22044329
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of malignancy and factors affecting outcome of cats undergoing splenectomy.
Rossanese M; Williams H; Puerta B; Scott P; Chanoit G; Guillén A
J Am Vet Med Assoc; 2023 Nov; 261(11):1646-1652. PubMed ID: 37582488
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
Borgatti A; Winter AL; Stuebner K; Scott R; Ober CP; Anderson KL; Feeney DA; Vallera DA; Koopmeiners JS; Modiano JF; Froelich J
PLoS One; 2017; 12(2):e0172651. PubMed ID: 28222142
[TBL] [Abstract][Full Text] [Related]
20. Canine splenic haemangiosarcoma: influence of metastases, chemotherapy and growth pattern on post-splenectomy survival and expression of angiogenic factors.
Göritz M; Müller K; Krastel D; Staudacher G; Schmidt P; Kühn M; Nickel R; Schoon HA
J Comp Pathol; 2013 Jul; 149(1):30-9. PubMed ID: 23276383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
